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Protein-Based Drugs in Perspective 
Since the commercial introduction of insulin in 1923, thyroid hormone in 1934, factor 
VIII in 1948, and calcitonin in 1970, plenty of new proteins have been firmly established 
as therapeutic agents. Currently there is great interest in production of the protein-based 
drugs which are used for both preventative and therapeutic purposes. Generally, the 
pharmaceutical proteins perform the same function as naturally-occurring proteins in 
body. Traditionally animal and plant sources have been used to obtain protein-based 
drugs which are indeed expensive and available in the limited supply. For instance, the 
human growth hormone was taken from human corpses and insulin required to treat 
diabetes was collected from slaughtered pigs, cows and other animals. Nowadays, the use 
of recombinant DNA (rDNA) technology has enabled the production of large quantities 
of protein drugs as cost-efficient sources. The cloned genes are then genetically 
engineered into microorganisms or animals to produce the protein of interest. Production 
of protein-based drugs in rDNA technology can be achieved through the transgenic 
animals (pharming), microorganisms or through hybridomas. Of the more than 200 
pharmaceutical proteins which have been investigated to date, more than half are 
undergoing research and development, about 100 are in clinical trials, and a dozen or so 
have already been marketed. The most important indications for them are cardiovascular 
disorders, tumors, autoimmune diseases, and infections. Overall, the protein-based drugs 
have found significant therapeutic potential, various clinical applications and growing 
market worldwide. On the other hand, several research centers/institutes in the field of 
life sciences have been established in our universities during the past decade. Now, these 
research centers and institutes could be pioneer for acquiring the big responsibility in 
different stages of production and commercialization of many protein-based drugs. 
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